Faeth Therapeutics FTH
NASDAQ FTH
$13.76 +0.84 (+6.46%)
As of: Nov 11, 2026 · 12:15 PM EST

Faeth Therapeutics (FTH) Shares Repurchased (2023)

Updated

Faeth Therapeutics (FTH) posted Shares Repurchased of $252,000 for Q4 2023, down 89.2% from the prior quarter.

Analysis

Faeth Therapeutics (FTH) Shares Repurchased (2023) Analysis & Trends

For FY2023, Faeth Therapeutics' Shares Repurchased came in at $10.38 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Faeth Therapeutics 333.88 Mn -244.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 252,000.00
Sep 30, 2023 2.34 Mn
API Access

Faeth Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=FTH&period=max&api_key=YOUR_API_KEY